European drug agency sets out plans to publish clinical trial data from 2014

The European Medicines Agency has set out how it intends to ensure greater access to clinical trial data. The year long process will see the new policy in force from 1 January 2014 and reflects the agency’s move towards a more proactive publication policy.1

The final route map reflects input from experts across the European healthcare system and the drug industry at a workshop in London on 22 November. The agency’s director, Guido Rasi, made clear to participants the new policy of publishing clinical trial data once the marketing authorisation …